Regulation

How Will Chile’s New Law Reshape Private Healthcare Insurers?
Business How Will Chile’s New Law Reshape Private Healthcare Insurers?

The recent legislative decision by the Chilean Congress marks a significant shift for the country's private healthcare system, specifically targeting the private insurers known as Isapres. The bill, designed to support the struggling sector, includes a mandate that these insurers must

Why Are Trust and Vendor Partnerships Crucial in Healthcare Tech?
Business Why Are Trust and Vendor Partnerships Crucial in Healthcare Tech?

Healthcare technology is advancing rapidly, offering innovative solutions that can revolutionize patient care and streamline operations. However, one critical factor stands at the forefront of successfully integrating these technologies: trust. Trust in vendors, the technology itself, and the data

How Can Automation Cut Costs in Cell and Gene Therapy Production?
Care How Can Automation Cut Costs in Cell and Gene Therapy Production?

Cell and gene therapy hold tremendous promise for treating a wide array of diseases, including many that were previously considered untreatable. However, the high production costs associated with these advanced treatments pose a significant barrier to their widespread adoption. Automation emerges

Latest Milestones and Breakthroughs in Cell and Gene Therapy
Care Latest Milestones and Breakthroughs in Cell and Gene Therapy

The fields of cell and gene therapy have seen remarkable advancements and transformative updates over the past few years. As biotechnology companies strive to innovate and deliver groundbreaking solutions, significant milestones have been achieved, fostering hope and optimism for addressing some of

Can the FDA Overcome Challenges in Postmarket Device Surveillance?
Public Policy Can the FDA Overcome Challenges in Postmarket Device Surveillance?

In an era marked by rapid advancements in medical technology, ensuring the safety and efficacy of medical devices remains paramount. The Food and Drug Administration (FDA) has been working diligently on developing a postmarket surveillance system, driven by a 2012 federal law aimed at reducing the

Breas Medical Corrects Vivo 45 LS Ventilators Due to Formaldehyde Risks
Organizational Governance Breas Medical Corrects Vivo 45 LS Ventilators Due to Formaldehyde Risks

Breas Medical has issued a significant correction involving their Vivo 45 LS ventilators, addressing potential formaldehyde exposure risks. This action impacts over 8,000 devices and comes after findings indicated that under specific conditions, patients could be exposed to harmful levels of

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later